Skip to main content
. 2014 Jun 4;14:103. doi: 10.1186/1471-230X-14-103

Table 2.

Frequency of individual symptoms irrespective of whether mild, moderate or severe (days per week)

 
Iron
Placebo
 
Symptom Treatment Wash-out Treatment Wash-out p value #
Nausea
1.1 ± 0.6
0.1 ± 0.1
0.2 ± 0.1
0.4 ± 0.4
0.2
(−0.3; 2.5)
(−0.1; 0.3)
(−0.1; 0.5)
(−0.5; 1.3)
Heartburn
1.0 ± 0.4
0.3 ± 0.3
0
0
0.03
(0.1; 1.9)
(−0.4; 1.0)
(0; 0)
(0; 0)
Abdominal pain
2.0 ± 0.6
1.0 ± 0.7
0.2 ± 0.1
0
0.02
(0.5; 3.5)
(−0.7; 2.7)
(−0.1; 0.5)
(0; 0)
Headache
1.1 ± 0.5
1.6 ± 0.6
0.2 ± 0.2
0.1 ± 0.1
0.15
(−0.1; 2.3)
(0.2; 3.0)
(−0.3; 0.7)
(−0.1; 0.3)
Breathlessness
0.1 ± 0.1
0.5 ± 0.3
0
0.1 ± 0.1
0.3
(−0.1; 0.3)
(−0.3; 1.3)
(0; 0)
(−0.1; 0.3)
Diarrohea
0.4 ± 0.3
0.3 ± 0.2
0.3 ± 0.3
0.4 ± 0.2
0.8
(−0.3; 1.1)
(−0.2; 0.8)
(−0.4; 1.0)
(−0.1; 0.9)
Constipation
1.0 ± 0.6
0.7 ± 0.5
0.2 ± 0.2
0
0.2
(−0.3; 2.3)
(−0.4; 1.8)
(−0.3; 0.7)
(0; 0)
Change bowel movements
1.3 ± 0.5
1.5 ± 0.3
0.4 ± 0.3
0.4 ± 0.2
0.15
(0.1; 2.5)
(0.7; 2.3)
(−0.2; 1.0)
(−0.1; 0.9)
Black stools
4.1 ± 0.7
1.3 ± 0.4
0
0
0.0004
(2.4; 5.8)
(0.4; 2.2)
(0; 0)
(0; 0)
  p = 0.002      

Values, derived from boxes ‘C’ and ‘H’ of the questionnaire (Figure 1), are shown as mean ± standard error (95% confidence interval) for the two groups.

#significance value (p < 0.05) between the frequency of each symptom for the Iron treatment period versus the Placebo treatment period.